REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviated Unaudited Accounts for the Year Ended 31 October 2014 |
|
for |
|
Biocillin Therapeutics Limited |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviated Unaudited Accounts for the Year Ended 31 October 2014 |
|
for |
|
Biocillin Therapeutics Limited |
Biocillin Therapeutics Limited (Registered number: 07394953) |
|
|
|
|
|
|
Contents of the Abbreviated Accounts |
for the Year Ended 31 October 2014 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Abbreviated Balance Sheet | 2 |
|
Notes to the Abbreviated Accounts | 4 |
Biocillin Therapeutics Limited |
|
Company Information |
for the Year Ended 31 October 2014 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
ACCOUNTANTS: |
|
Chartered Accountants |
|
|
|
|
|
|
|
|
BANKERS: |
|
|
|
|
|
|
|
|
|
|
SOLICITORS: |
|
|
|
|
|
Biocillin Therapeutics Limited (Registered number: 07394953) |
|
Abbreviated Balance Sheet |
31 October 2014 |
|
31.10.14 | 31.10.13 |
Notes | £ | £ |
FIXED ASSETS |
Intangible assets | 2 |
|
|
Tangible assets | 3 |
|
|
|
|
|
CURRENT ASSETS |
Stocks |
|
|
Debtors |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 4 | ( |
) | ( |
) |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one year | ( |
) | ( |
) |
NET LIABILITIES | ( |
) | ( |
) |
Biocillin Therapeutics Limited (Registered number: 07394953) |
|
Abbreviated Balance Sheet - continued |
31 October 2014 |
|
31.10.14 | 31.10.13 |
Notes | £ | £ |
CAPITAL AND RESERVES |
Called up share capital | 5 |
|
|
Profit and loss account | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) |
ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act
2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
|
|
|
|
The financial statements were approved by the Board of Directors on
|
|
|
|
|
|
|
|
|
|
|
Biocillin Therapeutics Limited (Registered number: 07394953) |
|
Notes to the Abbreviated Accounts |
for the Year Ended 31 October 2014 |
|
1. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
The accounts have been prepared on the going concern basis as the Director, Graham Papworth has guaranteed |
payment of the debts of the business.. |
|
Accounting convention |
The financial statements have been prepared under the historical cost convention and in accordance with the |
Financial Reporting Standard for Smaller Entities (effective April 2008). |
|
Turnover |
Turnover represents net invoiced sales of goods, excluding value added tax. |
|
Intangible fixed assets - intellectual property, trade marks and know how |
Intangible fixed assets are amortised on a straight line basis over 10 years, being their estimated useful life. |
|
Tangible fixed assets |
|
|
|
Stocks |
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow |
moving items. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet |
date. |
|
2. | INTANGIBLE FIXED ASSETS |
Total |
£ |
COST |
At 1 November 2013 |
and 31 October 2014 |
|
NET BOOK VALUE |
|
At 31 October 2014 |
|
At 31 October 2013 |
|
Biocillin Therapeutics Limited (Registered number: 07394953) |
|
Notes to the Abbreviated Accounts - continued |
for the Year Ended 31 October 2014 |
|
3. | TANGIBLE FIXED ASSETS |
Total |
£ |
COST |
At 1 November 2013 |
and 31 October 2014 |
|
DEPRECIATION |
At 1 November 2013 |
|
Charge for year |
|
At 31 October 2014 |
|
NET BOOK VALUE |
At 31 October 2014 |
|
At 31 October 2013 |
|
|
4. | CREDITORS |
|
Creditors include an amount of £
|
|
5. | CALLED UP SHARE CAPITAL |
|
Allotted and issued | Nominal value | £ |
700,000
|
£1 | 700,000 |
300,000
|
£1 | 300,000 |
1
|
£1 | 1 |
1,000,001 |
|
6. | ULTIMATE CONTROLLING PARTY |
|
|